Watchlist Price Alert

RAPT Therapeutics Inc. (RAPT)

NASDAQ: RAPT · Real-Time Price · USD

7.92

-0.32 (-3.88%)

At close: Jun 17, 2025, 10:20 AM

RAPT Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Net Income	-129.87M	-116.8M	-83.84M	-69.2M	-52.89M	-43M	-36.15M	-29.11M
Depreciation & Amortization	1.2M	1.22M	1.05M	996K	1.12M	1.33M	1.24M	1.38M
Stock-Based Compensation	19.93M	17.09M	11.26M	9.95M	8.69M	2.05M	1.17M	716K
Other Working Capital	34.37M	-1.84M	-5.04M	-5.23M	-46K	3.4M	-691K	-34K
Other Non-Cash Items	-477K	-4.06M	2.09M	1.53M	248K	20K	-14K	-9K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	-11K	17K	15K
Change in Working Capital	25.91M	5.5M	-1.33M	-4.3M	2.34M	4.13M	784K	-114K
Operating Cash Flow	-83.3M	-97.05M	-70.77M	-61.03M	-40.49M	-35.47M	-32.95M	-27.12M
Capital Expenditures	-122K	-1.13M	-845K	-755K	-398K	-888K	-3.5M	-1.12M
Cash Acquisitions	n/a	n/a	44.65M	80.59M	87.04M	45K	n/a	n/a
Purchase of Investments	-82.22M	-161.5M	-190.86M	-164.98M	-139.33M	n/a	n/a	n/a
Sales Maturities Of Investments	135.04M	266.75M	146.21M	84.39M	52.3M	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	-44.65M	-80.59M	-87.04M	45K	n/a	n/a
Investing Cash Flow	52.7M	104.13M	-45.49M	-81.35M	-87.44M	-843K	-3.5M	-1.12M
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	1.45M	1.39M	2.02M	1.85M	n/a	52.73M	30.1M
Financial Cash Flow	152.85M	1.45M	131.18M	141.48M	75.46M	49.9M	52.73M	30.1M
Net Cash Flow	122.26M	8.53M	14.92M	-891K	-52.47M	13.59M	16.28M	1.85M
Free Cash Flow	-83.42M	-98.17M	-71.62M	-61.78M	-40.89M	-36.36M	-36.45M	-28.25M